증진된 효능을 갖는 면역 이펙터 세포 요법

질환, 예를 들어, 종양 항원의 발현과 연관된 질환을 갖는 대상체를 치료하기 위한, 예를 들어 키메라 항원 수용체 (CAR)를 발현하도록 조작된 면역 이펙터 세포 (예를 들어, T 세포, NK 세포)의 사용 및 제조와 관련된 LSD1 억제제의 용도가 제공된다. The present invention relates generally to the use of LSD1 inhibitors in connection with use and manufacture of immune effector cells (e.g., T cells, NK c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ZHENG QIANGANG, LIU LEI, XUN GUOLIANG, MOTZ GREGORY, LIU JINBIAO, MAVRAKIAS KONSTANTINOS JOHN, XIAO QITAO
Format: Patent
Sprache:kor
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator ZHENG QIANGANG
LIU LEI
XUN GUOLIANG
MOTZ GREGORY
LIU JINBIAO
MAVRAKIAS KONSTANTINOS JOHN
XIAO QITAO
description 질환, 예를 들어, 종양 항원의 발현과 연관된 질환을 갖는 대상체를 치료하기 위한, 예를 들어 키메라 항원 수용체 (CAR)를 발현하도록 조작된 면역 이펙터 세포 (예를 들어, T 세포, NK 세포)의 사용 및 제조와 관련된 LSD1 억제제의 용도가 제공된다. The present invention relates generally to the use of LSD1 inhibitors in connection with use and manufacture of immune effector cells (e.g., T cells, NK cells), e.g., engineered to express a chimeric antigen receptor (CAR), to treat a subject having a disease, e.g., a disease associated with expression of a tumor antigen.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_KR20180099768A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>KR20180099768A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_KR20180099768A3</originalsourceid><addsrcrecordid>eNrjZLB8s2zum-UtryfMUXg7a8XrrqVv5rYovNow7XXXFIXXK7e8mb5W4c3cLW_7Zr5t2aDwpmXH2_41Cm9mTXm9aSoPA2taYk5xKi-U5mZQdnMNcfbQTS3Ij08tLkhMTs1LLYn3DjIyMLQwMLC0NDezcDQmThUAbeg_Ug</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>증진된 효능을 갖는 면역 이펙터 세포 요법</title><source>esp@cenet</source><creator>ZHENG QIANGANG ; LIU LEI ; XUN GUOLIANG ; MOTZ GREGORY ; LIU JINBIAO ; MAVRAKIAS KONSTANTINOS JOHN ; XIAO QITAO</creator><creatorcontrib>ZHENG QIANGANG ; LIU LEI ; XUN GUOLIANG ; MOTZ GREGORY ; LIU JINBIAO ; MAVRAKIAS KONSTANTINOS JOHN ; XIAO QITAO</creatorcontrib><description>질환, 예를 들어, 종양 항원의 발현과 연관된 질환을 갖는 대상체를 치료하기 위한, 예를 들어 키메라 항원 수용체 (CAR)를 발현하도록 조작된 면역 이펙터 세포 (예를 들어, T 세포, NK 세포)의 사용 및 제조와 관련된 LSD1 억제제의 용도가 제공된다. The present invention relates generally to the use of LSD1 inhibitors in connection with use and manufacture of immune effector cells (e.g., T cells, NK cells), e.g., engineered to express a chimeric antigen receptor (CAR), to treat a subject having a disease, e.g., a disease associated with expression of a tumor antigen.</description><language>kor</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20180905&amp;DB=EPODOC&amp;CC=KR&amp;NR=20180099768A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20180905&amp;DB=EPODOC&amp;CC=KR&amp;NR=20180099768A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ZHENG QIANGANG</creatorcontrib><creatorcontrib>LIU LEI</creatorcontrib><creatorcontrib>XUN GUOLIANG</creatorcontrib><creatorcontrib>MOTZ GREGORY</creatorcontrib><creatorcontrib>LIU JINBIAO</creatorcontrib><creatorcontrib>MAVRAKIAS KONSTANTINOS JOHN</creatorcontrib><creatorcontrib>XIAO QITAO</creatorcontrib><title>증진된 효능을 갖는 면역 이펙터 세포 요법</title><description>질환, 예를 들어, 종양 항원의 발현과 연관된 질환을 갖는 대상체를 치료하기 위한, 예를 들어 키메라 항원 수용체 (CAR)를 발현하도록 조작된 면역 이펙터 세포 (예를 들어, T 세포, NK 세포)의 사용 및 제조와 관련된 LSD1 억제제의 용도가 제공된다. The present invention relates generally to the use of LSD1 inhibitors in connection with use and manufacture of immune effector cells (e.g., T cells, NK cells), e.g., engineered to express a chimeric antigen receptor (CAR), to treat a subject having a disease, e.g., a disease associated with expression of a tumor antigen.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2018</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLB8s2zum-UtryfMUXg7a8XrrqVv5rYovNow7XXXFIXXK7e8mb5W4c3cLW_7Zr5t2aDwpmXH2_41Cm9mTXm9aSoPA2taYk5xKi-U5mZQdnMNcfbQTS3Ij08tLkhMTs1LLYn3DjIyMLQwMLC0NDezcDQmThUAbeg_Ug</recordid><startdate>20180905</startdate><enddate>20180905</enddate><creator>ZHENG QIANGANG</creator><creator>LIU LEI</creator><creator>XUN GUOLIANG</creator><creator>MOTZ GREGORY</creator><creator>LIU JINBIAO</creator><creator>MAVRAKIAS KONSTANTINOS JOHN</creator><creator>XIAO QITAO</creator><scope>EVB</scope></search><sort><creationdate>20180905</creationdate><title>증진된 효능을 갖는 면역 이펙터 세포 요법</title><author>ZHENG QIANGANG ; LIU LEI ; XUN GUOLIANG ; MOTZ GREGORY ; LIU JINBIAO ; MAVRAKIAS KONSTANTINOS JOHN ; XIAO QITAO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_KR20180099768A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>kor</language><creationdate>2018</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>ZHENG QIANGANG</creatorcontrib><creatorcontrib>LIU LEI</creatorcontrib><creatorcontrib>XUN GUOLIANG</creatorcontrib><creatorcontrib>MOTZ GREGORY</creatorcontrib><creatorcontrib>LIU JINBIAO</creatorcontrib><creatorcontrib>MAVRAKIAS KONSTANTINOS JOHN</creatorcontrib><creatorcontrib>XIAO QITAO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ZHENG QIANGANG</au><au>LIU LEI</au><au>XUN GUOLIANG</au><au>MOTZ GREGORY</au><au>LIU JINBIAO</au><au>MAVRAKIAS KONSTANTINOS JOHN</au><au>XIAO QITAO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>증진된 효능을 갖는 면역 이펙터 세포 요법</title><date>2018-09-05</date><risdate>2018</risdate><abstract>질환, 예를 들어, 종양 항원의 발현과 연관된 질환을 갖는 대상체를 치료하기 위한, 예를 들어 키메라 항원 수용체 (CAR)를 발현하도록 조작된 면역 이펙터 세포 (예를 들어, T 세포, NK 세포)의 사용 및 제조와 관련된 LSD1 억제제의 용도가 제공된다. The present invention relates generally to the use of LSD1 inhibitors in connection with use and manufacture of immune effector cells (e.g., T cells, NK cells), e.g., engineered to express a chimeric antigen receptor (CAR), to treat a subject having a disease, e.g., a disease associated with expression of a tumor antigen.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language kor
recordid cdi_epo_espacenet_KR20180099768A
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
title 증진된 효능을 갖는 면역 이펙터 세포 요법
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T15%3A01%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ZHENG%20QIANGANG&rft.date=2018-09-05&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EKR20180099768A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true